| Literature DB >> 31748538 |
Semen Yesylevskyy1,2, Timothée Rivel3, Christophe Ramseyer3.
Abstract
In this work the permeability of a model asymmetric plasma membrane, for ions, water and the anti-cancer drugs cisplatin and gemcitabine is studied by means of all-atom molecular dynamics simulations. It is shown for the first time that permeability of the highly curved membrane increases from one to three orders of magnitude upon membrane bending depending on the compound and the sign of curvature. Our results suggest that the membrane curvature could be an important factor of drug translocation through the membrane.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31748538 PMCID: PMC6868207 DOI: 10.1038/s41598-019-53952-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Simulated systems with the curvatures 0.2 nm−1 (top panel), 0.0 nm−1 (middle panel) and −0.2 nm−1 (bottom panel). Outer membrane leaflet is on top. PC is red, PE is blue, PS is violet, SM is orange and cholesterol is green (see Methods for definitions of abbreviations). N and P atoms of the lipid head group and the hydroxyl oxygen of cholesterol are shown as spheres. Black spheres show dummy particles which maintain the membrane shape. Black lines show approximate axes where the ligands are restrained during umbrella sampling simulations. Water molecules and ions are not shown for clarity.
Figure 2Potentials of mean force for studied ligands. The error bars are shown as semi-transparent bands.
Maximal heights of the energy barriers (kJ/mol).
| Curvature | Na+ | Cl- | Water | CPT | Gem |
|---|---|---|---|---|---|
| 0 | 101.1 | 101.6 | 31.4 | 70.1 | 77.5 |
| 0.2 | 98.3 (0.97) | 96.4 (0.95) | 30.2 (0.96) | 63.1 (0.90) | 64.8 (0.83) |
| −0.2 | 92.7 (0.92) | 93.4 (0.92) | 29.9 (0.95) | 66.7 (0.95) | 67.6 (0.87) |
Values in parentheses show relative height of the barrier with respect to the flat membrane for particular ligand.
Figure 3Diffusion coefficients of the studied ligands. The error bars are shown as semi-transparent bands.
Permeability coefficients (m∙s−1) for all studied ligands.
| Curvature, nm−1 | 0 | 0.2 | −0.2 |
|---|---|---|---|
| Water | 2.5∙10−6 ± 3.6∙10−8 | 5.5∙10−6 ± 7.2∙10−8 (2.1) | 3.7∙10−6 ± 5.3∙10−8 (1.5) |
| Na+ | 1.5∙10−17 ± 1.2∙10−18 | 8.4∙10−17 ± 6.9∙10−18 (5.3) | 1.7∙10−15 ± 1.3∙10−16 (107.5) |
| Cl- | 4.6∙10−17 ± 2.4∙10−18 | 1.5∙10−16 ± 8.7∙10−18 (3.2) | 6.4∙10−16 ± 3.3∙10−17 (13.8) |
| CPT | 2.3∙10−12 ± 6.2∙10−14 | 5.0∙10−11 ± 1.6∙10−12 (22.1) | 7.0∙10−12 ± 3.1∙10−13 (3.0) |
| Gem | 8.3∙10−14 ± 3.6∙10−15 | 1.4∙10−11 ± 4.2∙10−13 (164.5) | 4.5∙10−12 ± 1.5∙10−13 (53.7) |
Numbers in parentheses show the ratio of permeability in comparison to zero curvature for particular ligand.
Lipid content (absolute number of molecules) of the monolayers.
| Component | Outer monolayer | Inner monolayer |
|---|---|---|
| SM (sphingomyelin) | 42 | 12 |
| PC (1,2-dioleoyl-sn-glycero-3-phosphocholine) | 46 | 14 |
| PE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine) | 14 | 46 |
| PS (1,2-dioleoyl-sn-glycero-3-phospho-L-serine) | 0 | 30 |
| Cholesterol | 51 | 51 |
Initial cholesterol distribution is shown.